Figure 1From: Anophthalmia, hearing loss, abnormal pituitary development and response to growth hormone therapy in three children with microdeletions of 14q22q23 Facial photographs of the patients and their growth characteristics. (a) Patient 1 at the age of 6 months; (b) Patient 2 at the age of 7 months; (c) Patient 3 at the age of 22 months; (d) Development of body length with the onset of GH administration indicated by arrows.Back to article page